Downstream of tyrosine kinases-1 and src homology 2-containing inositol 5′-phosphatase are required for regulation of CD4+CD25+ T cell development

被引:48
作者
Kashiwada, Masaki
Cattoretti, Giorgio
McKeag, Lisa
Rouse, Todd
Showalter, Brian M.
Al-Alem, Umaima
Niki, Masaru
Pandolfi, Pier Paolo
Field, Elizabeth H.
Rothman, Paul B.
机构
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA
[4] Vet Affairs Med Ctr, Iowa City, IA 52246 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Human Genet, Program Mol Biol, New York, NY 10021 USA
关键词
D O I
10.4049/jimmunol.176.7.3958
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The adaptor protein, downstream of tyrosine kinases-1 (Dok-1), and the phosphatase SHIP are both tyrosine phosphorylated in response to T cell stimulation. However, a function for these molecules in T cell development has not been defined. To clarify the role of Dok-1 and SHIP in T cell development in vivo, We compared the T cell phenotype of wild-type, Dok-1 knockout (KO), SHIP KO, and Dok-1/SHIP double-knockout (DKO) mice. Dok-1/SHIP DKO mice were routed and had a shorter life span compared with either Dok-1 KO or SHIP KO mice. Thymocyte numbers from Dok-1/SHIP DKO mice were reduced by 90%. Surface expression of both CD25 and CD69 was elevated on freshly isolated splenic CD4(+) T cells from SHIP KO and Dok-1/SHIP DKO, suggesting these cells were constitutively activated. However, these T cells did not proliferate or produce IL-2 after stimulation. Interestingly, the CD4(+) T cells from SHIP KO and Dok-1/SHIP DKO mice produced higher levels of TGF-beta, expressed Foxp3, and inhibited IL-2 production by CD3-stimulated CD4(+)CD25(-) T cells in vitro. These findings suggest Dok-1 and SHIP function in pathways that influence regulatory T cell development.
引用
收藏
页码:3958 / 3965
页数:8
相关论文
共 48 条
[1]   SHIP modulates immune receptor responses by regulating membrane association of Btk [J].
Bolland, S ;
Pearse, RN ;
Kurosaki, T ;
Ravetch, JV .
IMMUNITY, 1998, 8 (04) :509-516
[2]   Differential regulation of B cell development, activation, and death by the Src homology 2 domain-containing 5′ inositol phosphatase (SHIP) [J].
Brauweiler, A ;
Tamir, I ;
Dal Porto, J ;
Benschop, RJ ;
Helgason, CD ;
Humphries, RK ;
Freed, JH ;
Cambier, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1545-1554
[3]   p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells [J].
Carpino, N ;
Wisniewski, D ;
Strife, A ;
Marshak, D ;
Kobayashi, R ;
Stillman, B ;
Clarkson, B .
CELL, 1997, 88 (02) :197-204
[4]  
Cong F, 1999, MOL CELL BIOL, V19, P8314
[5]   CHRONIC EXPOSURE TO TUMOR-NECROSIS-FACTOR (TNF) IN-VITRO IMPAIRS THE ACTIVATION OF T-CELLS THROUGH THE T-CELL RECEPTOR CD3 COMPLEX - REVERSAL IN-VIVO BY ANTI-TNF ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
COPE, AP ;
LONDEI, M ;
CHU, NR ;
COHEN, SBA ;
ELLIOTT, MJ ;
BRENNAN, FM ;
MAINI, RN ;
FELDMANN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :749-760
[6]   The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase [J].
Damen, JE ;
Liu, L ;
Rosten, P ;
Humphries, RK ;
Jefferson, AB ;
Majerus, PW ;
Krystal, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1689-1693
[7]   Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins [J].
Di Cristofano, A ;
Carpino, N ;
Dunant, N ;
Friedland, G ;
Kobayashi, R ;
Strife, A ;
Wisniewski, D ;
Clarkson, B ;
Pandolfi, PP ;
Resh, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4827-4830
[8]   p62dok, a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210bcr-abl [J].
Di Cristofano, A ;
Niki, M ;
Zhao, MM ;
Karnell, FG ;
Clarkson, B ;
Pear, WS ;
Van Aelst, L ;
Pandolfi, PP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) :275-284
[9]  
Edmunds C, 1999, EUR J IMMUNOL, V29, P3507, DOI 10.1002/(SICI)1521-4141(199911)29:11<3507::AID-IMMU3507>3.0.CO
[10]  
2-9